An observational study in Chronic Nonspecific Low Back Pain, sponsored by Medipol University. Not yet recruiting. Open to male participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Medipol University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to evaluate the pelvic floor and lumbopelvic stabilizer muscles (transversus abdominis, internal oblique, and lumbar multifidus) using ultrasonography in men with chronic nonspecific low back pain. Muscle morphology and activation will be assessed at rest and during different functional tasks to investigate potential alterations in muscle coordination and lumbopelvic stability. The findings may contribute to a better understanding of neuromuscular dysfunction and guide rehabilitation strategies.
Low back pain is a major musculoskeletal health problem with a high lifetime prevalence and is one of the leading causes of disability worldwide (1). In most cases, no specific pathological cause can be identified, and the condition is classified as nonspecific low back pain (2). When pain persists for more than three months, it is defined as chronic nonspecific low back pain, which negatively affects individuals' functional capacity, quality of life, and work participation (3). Multiple biomechanical, neuromuscular, psychosocial, and behavioral factors are thought to contribute to the development and persistence of chronic nonspecific low back pain (3).
In recent years, the concepts of lumbopelvic stability and motor control have gained increasing attention in explaining the underlying mechanisms of chronic low back pain. Lumbopelvic stabilization is a dynamic system resulting from the coordinated interaction of the spine, pelvis, and surrounding soft tissues through neuromuscular control. This system depends not only on passive structures but also on active muscular control and central nervous system integration (4, 5). Within this functional system, the transversus abdominis, internal oblique, lumbar multifidus, diaphragm, and pelvic floor muscles are considered key stabilizers. Rather than functioning independently, these muscles work synchronously through co-activation to maintain dynamic spinal stability. Therefore, dysfunction in any of these muscle groups may affect not only the individual muscle but also the overall coordination of the lumbopelvic stabilization system (6).
Delayed activation, reduced muscle thickness, atrophy, and impaired motor control of the transversus abdominis and lumbar multifidus muscles have been reported in individuals with chronic nonspecific low back pain (7, 8). Furthermore, recent studies have highlighted that the pelvic floor muscles play an important role not only in continence but also in maintaining lumbopelvic stability (6, 9). The pelvic floor muscles work in coordination with the transversus abdominis, multifidus, and diaphragm to regulate intra-abdominal pressure and contribute to spinal stabilization mechanisms (10). Consequently, impaired pelvic floor muscle function has been suggested to contribute to inadequate load transfer, altered motor control, and pain in the lumbopelvic region.
Although electromyography is widely used to assess muscle function, rehabilitative ultrasonography has emerged as a reliable, valid, and noninvasive method for examining muscle morphology and activation characteristics (11, 12). Ultrasonography enables real-time assessment of changes in muscle thickness and functional responses during muscle contraction. Ultrasonographic measurements have demonstrated high reliability, particularly in evaluating the activation of the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles (13, 14).
In the existing literature, the abdominal muscles, multifidus, and pelvic floor muscles have generally been investigated separately in individuals with chronic nonspecific low back pain (6, 15). However, studies simultaneously evaluating the functional behavior of the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles, which are essential components of the lumbopelvic stabilization system, remain limited (16). This limitation prevents a comprehensive understanding of functional coordination and potential co-activation impairments among these muscles (6). Moreover, research investigating the ultrasonographic activation characteristics of these muscles in men at rest, during the abdominal hollowing maneuver, and during voluntary pelvic floor muscle contraction is insufficient.
This study aims to address an important gap in the literature by comprehensively evaluating the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles within the same individuals under different functional conditions. While previous studies have predominantly examined these muscle groups separately, research assessing their functional behavior during rest and various activation tasks remains limited. Furthermore, most studies investigating the relationship between pelvic floor function and lumbopelvic stability have focused on female populations, resulting in insufficient ultrasonographic data regarding these muscles in men. Therefore, this study aims to investigate the functional synergy of lumbopelvic muscles in men with chronic nonspecific low back pain and contribute to the understanding of motor control mechanisms and the development of targeted clinical rehabilitation strategies.
2,926 studies on the registry are indexed under Low Back Pain; 579 are open to participants now.
This study's planned enrollment of 40 is below the median of 100 across 482 observational studies indexed under Low Back Pain.
Browse Low Back Pain studies →Medipol University is the lead sponsor of 327 studies on the registry; 87 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will consist of 40 male participants aged 18-65 years recruited at Medicana Bursa Hospital, Türkiye. Twenty participants with chronic nonspecific low back pain lasting at least three months will constitute the patient group, and 20 age-comparable healthy males without low back pain during the previous six months will constitute the control group. Pelvic floor and lumbopelvic stabilizer muscle function will be assessed using ultrasonography.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Chronic Nonspecific Low Back Pain Group:
Male participants aged 18-65 years.
Chronic nonspecific low back pain lasting at least 3 months.
(BMI) below 30 kg/m².
Ability to understand verbal instructions.
Willingness to participate voluntarily.
Provision of written .
Healthy Control Group:
Male participants aged 18-65 years.
No history of low back pain within the previous 6 months.
Body mass index (BMI) below 30 kg/m².
Ability to understand verbal instructions.
Willingness to participate voluntarily.
Provision of written informed consent.
Exclusion Criteria (Both Groups):
≥30 kg/m².
Regular sports exercise, core stabilization, Pilates, or pelvic floor exercises at least 3 days per week within the previous 6 months.
Employment involving heavy physical labor.
Specific spinal pathologies, including radiculopathy, spinal stenosis, spondylolisthesis, vertebral fracture, spinal infection, spinal tumor, or inflammatory spinal disease.
History of abdominal, pelvic, urinary tract, or lumbar surgery.
History of severe trauma affecting the lumbar region, pelvis, or lower extremities.
History of neurological disorders.
Urinary tract diseases, benign prostatic hyperplasia, urinary incontinence, or other urological conditions affecting pelvic floor function.
Umbilical or inguinal hernia.
Respiratory diseases associated with chronic cough.
Sacroiliac or hip joint pathologies.
Rheumatological, metabolic, or endocrine disorders affecting muscle function, such as diabetes mellitus or hypothyroidism.
History of .
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Twenty male participants aged 18-65 years with chronic nonspecific low back pain will undergo ultrasonographic assessment of pelvic floor and lumbopelvic stabilizer muscles.
Twenty age-comparable healthy male participants aged 18-65 years will undergo the same ultrasonographic assessments.
Pelvic Floor Muscle Function Assessed by Ultrasonography
Pelvic floor muscle function will be assessed using transabdominal ultrasonography by measuring bladder base displacement (mm) during voluntary pelvic floor muscle contraction and abdominal hollowing.
Time frame: Baseline (single assessment session)
Lumbopelvic Stabilizer Muscle Thickness and Contraction Ratios
ransversus abdominis, internal oblique, and lumbar multifidus muscle thickness (mm) will be measured using B-mode ultrasonography at rest, during abdominal hollowing, and during voluntary pelvic floor muscle contraction. Contraction ratios will be calculated as muscle thickness during activation divided by resting muscle thickness.
Time frame: Baseline (single assessment session)
Functional Disability Assessed by the Oswestry Disability Index (ODI)
Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI). The total score will be expressed as a percentage (0-100%), with higher scores indicating greater disability.
Time frame: Baseline (single assessment session)
Pain Intensity Assessed by the Numeric Rating Scale (NRS)
Pain intensity will be assessed using an 11-point Numeric Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants with chronic low back pain will report their average pain intensity during the previous week.
Time frame: Baseline (single assessment session)
Health-Related Quality of Life Assessed by EQ-5D-5L
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), covering mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. General health status will also be assessed using the EQ VAS (0-100).
Time frame: Baseline (single assessment session)
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.